Fungal infections in lung transplantation. Incidence, risk factors and prognostic significance

E Ruffini1, S Baldi, M Rapellino

  • 1Department of Thoracic Surgery, University of Torino, 3, Via Genova, 10126 Torino, Italy. enrico.ruffini@unito.it

Abstract

Insights

Fungal infections are common after lung transplants, often linked to bacterial infections, cytomegalovirus disease, and steroid use. However, these infections do not impact long-term survival rates in transplant recipients.

Area of Science:

  • Infectious Diseases
  • Transplantation Medicine
  • Pulmonology

Background:

  • Fungal infections pose a significant threat to lung transplant recipients, contributing to high mortality and morbidity.
  • Understanding the risk factors and outcomes of these infections is crucial for improving patient care.

Purpose of the Study:

  • To report institutional experience with fungal infections post-lung transplantation.
  • To identify correlations between fungal infections and bacterial infections, cytomegalovirus (CMV) disease, rejection, and steroid therapy.
  • To assess the impact of fungal infections on long-term survival after lung transplantation.

Main Methods:

  • A retrospective study of 60 lung transplant recipients.
  • Analysis of incidence, presentation patterns, and time to fungal infection.
  • Correlation analysis in 30 patients with at least 1-year follow-up.

Main Results:

  • Fungal infections occurred in 44% of patients, with severe infections in 11%.
  • Significant correlations were found between fungal infections and respiratory bacterial infections (p=0.0003), CMV disease (p=0.00001), and steroid therapy (p=0.04).
  • No statistically significant impact of fungal infection on long-term survival was observed (p=0.08).

Conclusions:

  • Fungal infections are frequent and can be severe in lung transplant recipients.
  • Preoperative fungal presence does not contraindicate transplantation; postoperative antifungal prophylaxis, such as aerosolized liposomal Amphotericin B, is recommended.
  • Fungal infections are associated with steroid therapy and CMV disease, suggesting prophylaxis in these scenarios. Fungal infection is not an independent predictor of long-term survival.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...